Abstract Expression of the receptor tyrosine kinase HER3 is negatively correlated with survival in ovarian cancer, and HER3 overexpression is associated with cancer progression and therapeutic resistance. Thus, improvements in HER3-targeted therapy could lead to significant clinical impact for ovarian cancer patients. Previous work from our group established multivalency as a potential strategy to improve the therapeutic efficacy of HER3-targeted ligands, including affibodies....
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Visual impairment in kurdistan and trend of epidemiologic eye studies in Iran Per Kallestrup Journal of Ophthalmic and Vision Research 2019 ...
-
Abstract Purpose This study examined the effect of different knee flexion angles with a constant hip and knee torque on the muscle force...
-
Objectives: To compare the hemodynamic response in septic shock patients receiving vasopressin who were on chronic renin-angiotensin-aldoste...
-
Objectives: To investigate the association between the concentration of the causative anions responsible for the main types of metabolic aci...
-
Academic Emergency Medicine, Volume 0, Issue ja , -Not available-. from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2x...
-
Publication date: October 2018 Source: The Journal of Emergency Medicine, Volume 55, Issue 4 Author(s): Reid Armstrong Haflich from Em...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου